BLUE RIVER HLDG(00498): Or Wai Chun has been appointed as authorized representative and process agent
BLUE RIVER HLDG (00498) announced that Mr. Kwong Kai Shing (Mr. Kwong) has submitted his resignation as an executive director, chairman and president of the Company with effect from 15 September 2026. Accordingly, Mr. Kwong will cease to act as the authorized representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the Stock Exchange), and the authorized representative of the Company for accepting service of process and notices in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (process agent).
BLUE RIVER HLDG (00498) announced that Mr. Kwong Kai Shing (Mr. Kwong) has submitted his resignation as an executive director, chairman and president of the Company with effect from September 15, 2026. Accordingly, Mr. Kwong will cease to act as the authorized representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the Stock Exchange), and as the authorized representative of the Company for accepting service of process and notices in Hong Kong under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) (process agent).
With effect from September 15, 2026, Mr. Or Wai Chun (the current executive director of the Company) has been appointed as the authorized representative and process agent of the Company with effect from September 15, 2026.
Related Articles

US Stock Market Move | Most chip stocks rise; Qualcomm (QCOM.US) gains over 4%

JIANGSU EXPRESS (00177) receives an increase in holdings of 49.856 million H shares by Yunshan Capital.

BASECARE-B(02170): GEMS Series Vitrification Solution and Thawing Solution Kit Obtains Class III Medical Device Registration Certificate Issued by the National Medical Products Administration
US Stock Market Move | Most chip stocks rise; Qualcomm (QCOM.US) gains over 4%

JIANGSU EXPRESS (00177) receives an increase in holdings of 49.856 million H shares by Yunshan Capital.

BASECARE-B(02170): GEMS Series Vitrification Solution and Thawing Solution Kit Obtains Class III Medical Device Registration Certificate Issued by the National Medical Products Administration

RECOMMEND





